Literature DB >> 2431819

The suppressive effect of gammaglobulin preparations on in vitro pokeweed mitogen-induced immunoglobulin production.

F Hashimoto, Y Sakiyama, S Matsumoto.   

Abstract

The effect of the supplementation with several gammaglobulin (GG) preparations on the in vitro immunoglobulin synthesis of peripheral blood mononuclear cells (PBMC) from normal subjects stimulated with pokeweed mitogen (PWM) was studied. Among the GG preparations used in this study, immune serum globulin (ISG) demonstrated the most suppressive effect, and S-sulfonation and polyethylene glycol (PEG)-treated preparations also had a suppressive effect. However, the preparation of pepsin degradation had no suppressive effect. And because IgG F(ab')2 fragments also failed to induce the suppressive effect, it was considered to be triggered by the attachment of the Fc portion of GG to the corresponding membrane receptor. To determine the cellular targets, PBMC were fractionated into E-rosetting cells (T cells) and non E-rosetting cells (B cells). The suppressive effect was induced by pre-incubation of either T cells or B cells with the GG preparations for 1 h, at 37 degrees C in PWM-induced immunoglobulin (Ig) production. The failure of T cells pretreated with OKT8 monoclonal antibody and complement to induce the suppressive effect suggested that T8 positive T cells are one of the effector cells involved. The activation step of the suppressive effect was prostaglandin E2-independent, and as effector cells contain an Fc receptor which is sensitive to pronase, it was suggested that monocytes were not involved in this activation process. Our observations further suggested that the Ig effects of GG therapy are not limited to antibody transfer, since GG preparations also suppress directly the differentiation of B cells and induce suppressor T cells in in vitro immunoglobulin production stimulated with PWM.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431819      PMCID: PMC1542318     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Insoluble immune complexes suppress mitogen-induced proliferation of human T lymphocytes bearing Fc gamma receptors.

Authors:  C Samarut; G Cordier; J P Revillard
Journal:  Cell Immunol       Date:  1979-01       Impact factor: 4.868

2.  In vivo behaviour of gamma globulin preparations.

Authors:  A Morell; B Schürch; D Ryser; F Hofer; F Skvaril; S Barandun
Journal:  Vox Sang       Date:  1980       Impact factor: 2.144

3.  Individualization of gamma globulin dosage in patients with humoral immunodeficiency.

Authors:  R I Schiff; C Rudd; R Johnson; R H Buckley
Journal:  Birth Defects Orig Artic Ser       Date:  1983

4.  Aggregated IgG-induced suppression of in vitro antibody responses: definition of the cellular target(s).

Authors:  J K Nicholson; J S McDougal
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

5.  Two distinct mechanisms of immune suppression by antibody.

Authors:  M K Hoffmann; J W Kappler
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

6.  Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content.

Authors:  J Römer; J J Morgenthaler; R Scherz; F Skvaril
Journal:  Vox Sang       Date:  1982-02       Impact factor: 2.144

7.  Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy.

Authors:  A Durandy; A Fischer; C Griscelli
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  Distribution and properties of Fc receptors for IgG on different leucocyte populations in man.

Authors:  M Colombatti; D Heumann; L Moretta
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

9.  Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity.

Authors:  A Fischer; A Durandy; C Griscelli
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  9 in total

1.  Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro.

Authors:  I N van Schaik; I Lundkvist; M Vermeulen; A Brand
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

2.  The growth arresting effect of human immunoglobulin for intravenous use is mediated by antibodies recognizing membrane glycolipids.

Authors:  W M Vuist; I N Van Schaik; M Van Lint; A Brand
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

3.  Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin.

Authors:  N Kondo; T Ozawa; K Mushiake; F Motoyoshi; T Kameyama; K Kasahara; H Kaneko; M Yamashina; Y Kato; T Orii
Journal:  J Clin Immunol       Date:  1991-05       Impact factor: 8.317

4.  Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin.

Authors:  M Toyoda; X Zhang; A Petrosian; O A Galera; S J Wang; S C Jordan
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

5.  Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulin.

Authors:  H Becker; G Mitropoulou; K Helmke
Journal:  Klin Wochenschr       Date:  1989-03-01

Review 6.  In vitro effects of polyvalent immunoglobulin for intravenous use.

Authors:  I N van Schaik; M Vermeulen; A Brand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

7.  In vitro synthesis of human IgE is suppressed by human IgG.

Authors:  H Haas; M Schlaak
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

8.  B-cell and T-regulatory cell dysfunction in six Chinese children with hypogammaglobulinaemia.

Authors:  B M Jones; Y L Lau; K L Wong
Journal:  Eur J Pediatr       Date:  1993-05       Impact factor: 3.183

9.  Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production.

Authors:  S Heidt; D L Roelen; C Eijsink; M Eikmans; F H J Claas; A Mulder
Journal:  Clin Exp Immunol       Date:  2009-10       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.